BioSpace News Archive

Telo Genomics Launches Physician Experience Program in the United States

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), (the “Company” or “Telo”), an emerging molecular testing platform provider leveraging the power of telomeres

November 16, 2023
·
5 min read
Viral Vectors & Plasmid DNA Manufacturing Market Size to Surpass USD 5,989.21 Million by 2032

The global viral vectors & plasmid DNA manufacturing market size reached USD 1,237.45 million in 2022 and is expected to surpass around USD 5,989.21 million by 2032

November 16, 2023
·
11 min read
Pharm Country

NYU Langone Health to adopt new Philips health technology solutions in multi-year partnership directed at patient safety, quality and outcomes

Royal Philips and NYU Langone Health announced an 8-year strategic partnership valued up to USD 115 million and aimed at enhancing patient care through further innovation.

November 16, 2023
·
4 min read
Pharm Country

Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023

Aptorum Group Limited announced that it will hold its 2023 annual general meeting of shareholders at its London office located at 17 Hanover Square, Mayfair London, England W1S 1BN at 1:00 p.m. London Time on December 20, 2023.

November 16, 2023
·
4 min read
First Human Clinical Study to Assess U.S. Department of Defense DNA Vaccine Candidate against Venezuelan Equine Encephalitis Delivered with PharmaJet Precision Delivery Systems.

PharmaJet®, a company that has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced the start of the first human clinical trial for a Venezuelan Equine Encephalitis (VEE) vaccine delivered with PharmaJet Precision Delivery Systems.

November 16, 2023
·
4 min read
Lone Star Bio

Gradalis Awarded $9.9 Million Grant From the Cancer Prevention and Research Institute of Texas

Gradalis, Inc. announced that it has been awarded a $9.9 million Product Development Research grant from the Cancer Prevention and Research Institute of Texas.

November 16, 2023
·
9 min read
Genetown

GENFIT Highlights ACLF Development Strategy at “ACLF Day” during AASLD The Liver Meeting® 2023

GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the highlights from its “ACLF Day” held on November 11, 2023 during AASLD The Liver Meeting ® in Boston, MA (USA).

November 16, 2023
·
10 min read
Biotech Bay

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 16, 2023

Geron Corporation, a late-stage clinical biopharmaceutical company, reported that it has granted non-statutory stock options to purchase an aggregate of 438,950 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.

November 16, 2023
·
2 min read
Business

Halia Therapeutics Appoints Former Amgen Scientists, Lisa Shamon, Ph.D., as Vice President of Regulatory Affairs and Xianne Leong Penny, Ph.D., as Senior Medical Director

Halia Therapeutics today announced the appointment of Lisa Shamon , Ph.D., as the company’s Vice President Regulatory Affairs.

November 16, 2023
·
3 min read
Pharm Country

HARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 35th ANNUAL HEALTHCARE CONFERENCE

Harmony Biosciences Holdings, Inc. today announced that Harmony’s management team will participate in a fireside chat at the upcoming Piper Sandler 35th Annual Healthcare Conference in New York, NY on Thursday, November 30, 2023, at 9:00 a.m. ET.

November 16, 2023
·
1 min read